Mycoplasma pneumoniae-associated Hepatitis without Lung Involvement

Han Taek Jeong1, Jae Young Oh1, Jung Eun Song1

  • 1Division of Gastroenterology, Department of Internal Medicine, Daegu Catholic University Medical Center, Catholic University of Daegu School of Medicine, Daegu, Korea.

Insights

Mycoplasma pneumoniae can cause acute hepatitis, even without lung symptoms. Early macrolide treatment rapidly improved this rare extrapulmonary manifestation in a patient.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Pulmonology

Background:

  • Mycoplasma pneumoniae is a common cause of respiratory infections.
  • Extrapulmonary manifestations of Mycoplasma pneumoniae are known but typically involve cardiovascular, dermatological, musculoskeletal, and hematological systems.
  • Acute hepatitis as an isolated presentation of Mycoplasma pneumoniae in adults is rare.

Observation:

  • A 32-year-old male presented with fever, chills, myalgia, and headache.
  • Biochemical analysis revealed severely impaired liver function and leukopenia.
  • Laboratory tests and liver biopsy confirmed a hepatocellular pattern of acute hepatitis.

Findings:

  • The patient was diagnosed with Mycoplasma pneumoniae-associated acute hepatitis.
  • Hepatocellular injury pattern was identified.
  • Rapid clinical and laboratory improvement was observed following macrolide treatment.

Implications:

  • Mycoplasma pneumoniae should be considered in the differential diagnosis of acute hepatitis, particularly when lung or other extrapulmonary involvement is absent.
  • Prompt diagnosis and treatment with macrolides can lead to rapid recovery.
  • This case highlights the diverse clinical spectrum of Mycoplasma pneumoniae infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
966
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K